These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24910416)

  • 1. Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients.
    Muendlein A; Hubalek M; Geller-Rhomberg S; Gasser K; Winder T; Drexel H; Decker T; Mueller-Holzner E; Chamson M; Marth C; Lang AH
    Eur J Cancer; 2014 Aug; 50(12):2134-41. PubMed ID: 24910416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients.
    Lang AH; Geller-Rhomberg S; Winder T; Stark N; Gasser K; Hartmann B; Kohler B; Grizelj I; Drexel H; Muendlein A
    BMC Cancer; 2012 Jan; 12():20. PubMed ID: 22251819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation.
    Zheng Z; Gao S; Yang Z; Xie H; Zhang C; Lin B; Wu L; Zheng S; Zhou L
    Int J Med Sci; 2014; 11(2):142-50. PubMed ID: 24465159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study.
    Dai ZJ; Liu XH; Kang HF; Wang XJ; Jin TB; Zhang SQ; Feng T; Ma XB; Wang M; Feng YJ; Liu K; Xu P; Guan HT
    Medicine (Baltimore); 2016 Feb; 95(6):e2801. PubMed ID: 26871844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer.
    Muendlein A; Lang AH; Geller-Rhomberg S; Winder T; Gasser K; Drexel H; Decker T; Mueller-Holzner E; Chamson M; Marth C; Hubalek M
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):491-8. PubMed ID: 23180020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Borm GF; Tjan-Heijnen VC
    Breast Cancer Res Treat; 2013 Oct; 141(3):507-14. PubMed ID: 24104881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer.
    Maae E; Andersen RF; Steffensen KD; Jakobsen EH; Brandslund I; Sørensen FB; Jakobsen A
    Anticancer Res; 2012 Sep; 32(9):3619-27. PubMed ID: 22993299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer.
    Schmid F; Burock S; Klockmeier K; Schlag PM; Stein U
    Mol Cancer; 2012 Jul; 11():49. PubMed ID: 22838389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
    Lederer A; Herrmann P; Seehofer D; Dietel M; Pratschke J; Schlag P; Stein U
    Hepatology; 2015 Sep; 62(3):841-50. PubMed ID: 25953673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of MACC1 expression and its regulation of the HGF/c‑Met pathway between breast and colorectal cancer.
    Sueta A; Yamamoto Y; Yamamoto-Ibusuki M; Hayashi M; Takeshita T; Yamamoto S; Omoto Y; Iwase H
    Int J Oncol; 2015 May; 46(5):2143-53. PubMed ID: 25738887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
    Johnston S; Pippen J; Pivot X; Lichinitser M; Sadeghi S; Dieras V; Gomez HL; Romieu G; Manikhas A; Kennedy MJ; Press MF; Maltzman J; Florance A; O'Rourke L; Oliva C; Stein S; Pegram M
    J Clin Oncol; 2009 Nov; 27(33):5538-46. PubMed ID: 19786658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
    Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
    Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
    J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer.
    Hisamatsu Y; Tokunaga E; Yamashita N; Akiyoshi S; Okada S; Nakashima Y; Aishima S; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 Apr; 19(4):1145-52. PubMed ID: 21984487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HER2 and its association with AP-2 in breast cancer.
    Pellikainen J; Naukkarinen A; Ropponen K; Rummukainen J; Kataja V; Kellokoski J; Eskelinen M; Kosma VM
    Eur J Cancer; 2004 Jul; 40(10):1485-95. PubMed ID: 15196531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of renin-angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran.
    Namazi S; Daneshian A; Mohammadianpanah M; Jafari P; Ardeshir-Rouhani-Fard S; Nasirabadi S
    Gene; 2013 Dec; 532(1):125-31. PubMed ID: 24055489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.